These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Hyogo H; Tazuma S; Arihiro K; Iwamoto K; Nabeshima Y; Inoue M; Ishitobi T; Nonaka M; Chayama K Metabolism; 2008 Dec; 57(12):1711-8. PubMed ID: 19013295 [TBL] [Abstract][Full Text] [Related]
16. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis. Das K; Kar P J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603 [TBL] [Abstract][Full Text] [Related]
18. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology. Ahmed MH Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367 [No Abstract] [Full Text] [Related]
19. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Younossi ZM Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557 [TBL] [Abstract][Full Text] [Related]
20. ["Alcoholic" liver damage in nonalcoholics. Nonalcoholic steatohepatitis]. Dancygier H Dtsch Med Wochenschr; 1997 Sep; 122(39):1183-8. PubMed ID: 9378036 [No Abstract] [Full Text] [Related] [Next] [New Search]